RNAi Therapies: Drugging the Undruggable-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RNAi Therapies: Drugging the Undruggable

Published:2014-06-11 Issue:240 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Wu Sherry Y.¹,Lopez-Berestein Gabriel²³,Calin George A.²³,Sood Anil K.¹³⁴

Affiliation:

1. Departments of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.

2. Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.

3. Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.

4. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.

Abstract

New strategies are required to make RNA interference therapeutics a viable tool for cancer management.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference30 articles.

1. First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

2. T. Golan A. Hubert A. Shemi A. Segal A. Dancour E. Z. Khvalevsky “A phase I trial of a local delivery of siRNA against k-ras in combination with chemotherapy for locally advanced pancreatic adenocarcinoma ” paper presented at the 49th Annual Meeting of the American Society of Clinical Oncology Chicago IL (2013).

3. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

4. Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

5. Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transformative approaches for siRNA detection;OpenNano;2024-11

2. Ionizable Drugs Enable Intracellular Delivery of Co‐Formulated siRNA;Advanced Materials;2024-08-15

3. Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy;Small;2024-03-05

4. SiRNA-HIF-1α delivered by attenuated Salmonella enhances the efficacy of Lenvatinib against hepatocellular carcinoma;International Immunopharmacology;2024-03

5. Control of the Assembly and Disassembly of Spherical Nucleic Acids Is Critical for Enhanced Gene Silencing;ACS Nano;2024-01-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3